Company: RCUS
Filing Date: 2025-12-18
Form Type: 8-K
Source: 0001724521-25-000122
Chunk: 1

Company: Arcus Biosciences, Inc.
Filing Date: 2025-12-18
Form: 8-K
Item: Item 1.01
Chunk 1
---
 amount equal to or greater than 50.0% of the aggregate outstanding principal amount of the secured obligations or (B) Qualified Cash in an aggregate amount equal to or greater than 100.0% of the aggregate outstanding principal amount of the secured obligations or (ii) certain net product revenue thresholds.

The foregoing is only a brief description of the material terms of the First Amendment does not purport to be a complete description of the amendment and is qualified in its entirety by reference to such amendment, which will be filed as an exhibit to the Company’s Annual Report on Form 10-K for the year ending December 31, 2025.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.